Journal of Community Hospital Internal Medicine Perspectives
Volume 12

Issue 6

Article 10

2022

POEMS syndrome - a diagnostic dilemma with challenging
presentation
Mosunmoluwa Oyenuga
Department of Internal Medicine, SSM Health St. Mary's Hospital-St. Louis, oyenugamosun@gmail.com

Mohamed M. G. Mohamed
Department of Internal Medicine, SSM Health St. Mary's Hospital-St. Louis

Rushin Patel
Department of Internal Medicine, SSM Health St. Mary's Hospital-St. Louis

Sara Sartaj
Department of Internal Medicine, SSM Health St. Mary's Hospital-St. Louis

Sandeep Sen
Division of Hematology and Medical Oncology, SSM Health St. Mary’s Hospital-St. Louis,

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.gbmc.org/jchimp

Recommended Citation
Oyenuga, Mosunmoluwa; Mohamed, Mohamed M. G.; Patel, Rushin; Sartaj, Sara; Sen, Sandeep; Lacasse,
Alexandre; and Kumar, Vikas (2022) "POEMS syndrome - a diagnostic dilemma with challenging
presentation," Journal of Community Hospital Internal Medicine Perspectives: Vol. 12: Iss. 6, Article 10.
DOI: 10.55729/2000-9666.1121
Available at: https://scholarlycommons.gbmc.org/jchimp/vol12/iss6/10

This Case Report is brought to you for free and open access by the Journal at GBMC Healthcare Scholarly
Commons. It has been accepted for inclusion in Journal of Community Hospital Internal Medicine Perspectives by
an authorized editor of GBMC Healthcare Scholarly Commons. For more information, please contact
GBMCcommons@gbmc.org.

POEMS syndrome - a diagnostic dilemma with challenging presentation
Authors
Mosunmoluwa Oyenuga, Mohamed M. G. Mohamed, Rushin Patel, Sara Sartaj, Sandeep Sen, Alexandre
Lacasse, and Vikas Kumar

This case report is available in Journal of Community Hospital Internal Medicine Perspectives:
https://scholarlycommons.gbmc.org/jchimp/vol12/iss6/10

Mosunmoluwa Oyenuga a,*, Mohamed M.G. Mohamed a, Rushin Patel a, Sara Sartaj a,
Sandeep Sen b, Alexandre Lacasse a, Vikas Kumar c
a

Department of Internal Medicine, SSM Health St. Mary's Hospital-St. Louis, MO, USA
Division of Hematology and Medical Oncology, SSM Health St. Mary's Hospital-St. Louis, MO, USA
c
Division of Neurology, SSM Health St. Mary's Hospital-St. Louis, MO, USA
b

Abstract
Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, Skin changes (POEMS) syndrome is a rare disorder with
multiple presentations and a constellation of symptoms. We present a 62 year-old female who presented to the Emergency Department for acute dyspnea. Chest Xray showed sclerotic lesions in the ribs and thoracic spine. Further imaging
studies with computed tomography (CT) and positron emission tomography (PET) scans were suggestive of a benign
process. Improvement was seen with supportive management. A few months later, patient developed neurological
symptoms with reduced exercise tolerance. Mixed demyelinating and axonal polyneuropathy was diagnosed by electromyography. Further work up with bone marrow biopsy and immunochemistry testing revealed lambda and kappa
plasma cell disorder, with elevated vascular endothelial growth factor (VEGF). Patient was diagnosed with POEMS and
initiated on chemotherapy. POEMS syndrome is commonly missed due to its rarity and varied clinical presentations.
VEGF plays a crucial role in the diagnosis. Management requires a multidisciplinary approach.
Keywords: POEMS syndrome, Polyneuropathy, Plasma cell disorder, VEGF, Vascular endothelial growth factor, Organomegaly, Endocrinopathy, M-protein, Skin changes syndrome, Demyelinating, Neuropathy

1. Introduction

P

OEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, and Skin
changes) syndrome is a rare constellation of clinical
signs and symptoms involving multiple systems.
The mandatory criteria for diagnosis include polyneuropathy and plasma cell disorder.1 Patients
commonly present with varied symptoms which
make up the acronym “POEMS” and other
nonspeciﬁc signs and symptoms including ascites,
pleural effusion, and thrombocytosis. Due to its
nonspeciﬁc presentation, diagnosis is often missed
or delayed. Patients can sometimes be diagnosed
with a primary neurologic disorder such as Chronic
Inﬂammatory
Demyelinating
Polyradiculoneuropathy (CIDP).1 The exact prevalence
in the US remains unknown despite reported cases

in the literature. The pathophysiology of POEMS
remains unclear. Elevated levels of vascular endothelial growth factor (VEGF) have been implicated
in the majority of cases and. is currently used as a
marker to aid diagnose and monitor disease activity.2,3 We describe a case of POEMS and our
approach to diagnosis and management.

2. Case
A 62 year-old female with a past medical history
of hypertension and asthma presented to the
Emergency Department with acute dyspnea. Chest
Xray showed sclerotic foci of T11 vertebrae, right
ﬁrst rib, and left 5th rib. Treatment for asthma
exacerbation was provided and advised to follow up
on an out-patient basis. Further evaluation with a
Computed Tomography (CT) scan showed multiple
sclerotic lesions scattered throughout the spine and
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pelvis with increased uptake in the femur concerning for metastatic disease. Positron Emission Tomography (PET) scan showed similar ﬁndings with
subtle increased metabolic activity suggestive of a
benign process (Fig. 1). Close monitoring with
repeat imaging a year later showed stable lesions.
Approximately six months later, the patient developed slow progressive tingling and numbness in
both feet as well as reduced exercise intolerance.
Further clinical evaluation by the neurology service
revealed an underlying peripheral neuropathy.
Electromyography (EMG) showed severe mixed
demyelinating-axonal sensorimotor polyneuropathy
with asymmetric active denervation, ﬁndings of
conduction block and temporal dispersion (Fig. 2).

Fig. 1. Positron emission tomography (PET) scan with increased metabolic activity to the right femur.

Comprehensive motor sensory neuropathy laboratory panel was positive for perinuclear anticytoplasmic neutrophil antibodies (pANCA) (titer1:160) and elevated rheumatoid factor (28 IU/ml
(range - <14 IU/ml). Cerebrospinal ﬂuid (CSF)
analysis showed elevated myelin basic protein
without oligoclonal bands, although four paired
bands were observed. CSF immunoﬁxation electrophoresis did not show any monoclonal bands.
Magnetic resonance imaging (MRI) of the brain
showed diffuse dural enhancement and thickening
(Fig. 3). Further rheumatological laboratory workup
was unremarkable. Oral prednisone was initiated
for possible inﬂammatory neuropathy. Some
improvement in ambulation was noted. Bone
marrow aspirate showed trilineage hematopoiesis,
megakaryocytic hyperplasia, mild plasmacytosis
(10% by immunohistochemistry), mild excess in
lambda expressing plasma cells, and thickened
bone trabeculae consistent with osteosclerosis.
Immunoglobulin G subtype 4 (IgG4) immunoperoxidase stain was negative. Serum immunoﬁxation
showed a normal immunoglobulin panel and
elevated free kappa (23.6 mg/L (range 3.3e19.4mg/
L) and lambda chains (32.0 mg/L (range 5.7e26.3
mg/L). Kappa-to-lambda ratio was normal. Biopsy
of the T11 thoracic vertebral sclerotic lesion showed
osteosclerosis. VEGF was elevated 1380 pg/ml
(normal 0e115 pg/ml). Diagnosis of POEMS was
established based on known criteria.1 No evidence
of endocrinopathy was seen upon further testing.
Abdominal computed tomography (CT) imaging
showed mild splenomegaly. Echocardiography
showed normal ejection fraction of 60%, grade 1

Fig. 2. Nerve Conduction Study illustrating a) temporal dispersion of the left peroneal nerve b) conduction block in the right ulnar motor nerve.

Fig. 3. Magnetic Resonance Imaging (MRI) brain showing diffuse
thickening and enhancement of the dura.

diastolic dysfunction and no wall abnormalities.
Pulmonary function test showed mild obstructive
ventilatory defect consistent with asthma. Oncology
evaluation was performed. Chemotherapy using
daratumumab, lenalidomide, and dexamethasone
was initiated. Some improvement in neurological
symptoms ensued. Autologous stem cell transplantation has been planned.

3. Discussion
Diagnosis of POEMS syndrome remains challenging due its rarity and associated multiple clinical presentations. It is often misdiagnosed or
diagnosed later in the disease course. Based on
previous literature and as seen with our patient,
diagnosis can be achieved approximately one to two
years after initial symptom presentation.4,5 Common misdiagnosis include CIDP, Monoclonal
Gammopathy of Undetermined Signiﬁcance
(MGUS) or multiple myeloma.6
In our patient, brain imaging ﬁndings were nonspeciﬁc and revealed diffuse dural thickening and
enhancement. In a retrospective study of MRI brain
ﬁndings in patients with POEMS, approximately
seventy percent of patients had asymptomatic
pachymeningeal involvement.7 This ﬁnding may
help to differentiate POEMS from other neurological disorders and may be an important diagnosis
criterion to be added.
POEMS should be suspected in patients with
ﬁndings of osteosclerosis along with progressive
polyneuropathy. Many patients will in fact present
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with only few signs and symptoms included in the
established diagnosis criteria.6 Most patients present
in the fourth to ﬁfth decade of life with male predominance though a wide age range has been previously reported.8 As seen in our patient, sclerotic
lesions can be found in up to 95% of patients with
POEMS with a lower prevalence in patients from
China.9,10 Contrary to our patient, further evaluation
with a bone marrow biopsy can sometimes help
reach a deﬁnitive diagnosis as monoclonal plasma
cells may be seen.11,12 Although not necessary to
establish a diagnosis of POEMS, other previously
reported clinical features include: thrombocytosis,
polycythemia, and skin changes. As noted in a recent
retrospective study of 108 patients with POEMS,
these features were less frequently reported.13
The pathophysiology of POEMS remains unclear.
VEGF has been described as a marker of disease
activity.14 Markedly elevated levels are seen in patients with POEMS syndrome. Moreover, when
used in combination with clinical symptoms, VEGF
levels can be used to distinguish POEMS from other
plasma cell dyscrasias or other conditions in which
it can be elevated.15 Early diagnosis remains
important as treatment of POEMS signiﬁcantly differs from other mimicking diseases. Depending on
the extent of the disease, as with patients with a
solitary plasmacytoma, radiation therapy remains
the ﬁrst line of treatment. Patients with diffuse
sclerotic lesions receive chemotherapy and if
eligible, stem cell transplant.
In conclusion, diagnosis of POEMS syndrome
requires a high index of clinical suspicion. With
advancement in management, early diagnosis can
help to reduce or prevent disabling symptoms,
morbidity, and mortality.16 Incidental ﬁnding of
sclerotic bone lesions should raise suspicion and
prompt further workup to lead to an earlier diagnosis of POEMS syndrome, more so when polyneuropathy is also present.
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